Multiple sclerosis (MS) is a chronic disease which affects the brain and spinal cord. MS can cause a variety of symptoms, including changes in sensation, visual problems, muscle we...
|
drug for cognitive impairment
|
Watch this |
| View More Posts Ignore |
Memantine for MS cognitive impairment
This year OHSU, in collaboration with USC, has conducted a double blind placebo-controlled pilot trial of memantine for cognitive impairment in MS. Memantine is a glutamate receptor antagonist that has been shown to improve cognition in Alzheimer's disease. This trial is designed to assess whether memantine will improve cognition among MS patients. Eighty patients have already been enrolled in the study. Look out for it! Posted on 06/04/08, 04:06 pm |
| 3 Replies | Add Your Reply |
| View More Posts Ignore |
sign me up before I forget 
|
|
|
|
||
| View More Posts Ignore |
SuperDave--Sorry, I am inline first. Leanna
|
|
|
|
||
| View More Posts Ignore |
ROFL at Superdave...great comment.
I forget stuff all the time, or I confuse things, like I have suddenly developed a case of MS induced dyslexia...grrrrrrr!
|
|
|
|
||
Acorda Therapeutics Announces Positive Data from Second Phase 3 Study of Fampridine-SR on Walking Ability in People …
It's brief, I think I will post it …
BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple …
